Pulmonx Corp — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-09-01

Reporting Person: Sullivan Tiffany (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-01	Common Stock	A	4610	$0.00	Acquired	4610	Direct

Footnotes

F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest in three equal annual installments from the grant date of September 1, 2021.